>peptide 1 (47 aa)
MLSFLHFSFKYLSCCFIDFLIQCCKSPNSSPKKIEVTIFIGLCTVLY*
>peptide 2 (57 aa)
MLQIAKLLTQKDRSYNFHWSVYGVILRASPGVAVKLCLGDLLVMGSNPETASLHMQG*
>peptide 3 (36 aa)
MLLCFLFYISLLNICHVVLLISLFNAANRQTPHPKR*
>CNT0001962
TGTTGACAACTATGGTTCCAGAAAATTTAAGCTTCCAATGGACACTTACACCTTAAGTTCCAGATAAACTTCTTTTAGATGTGTCCATTTTGCCATATAT
GCTACTATGCTTTCTTTTTTACATTTCTCTTTTAAATATTTGTCATGTTGTTTTATTGATTTCCTTATTCAATGCTGCAAATCGCCAAACTCCTCACCCA
AAAAGATAGAAGTTACAATTTTCATTGGTCTGTGTACGGTGTTATACTGAGGGCGAGCCCTGGTGTAGCGGTAAAGTTGTGCCTTGGTGACTTGTTGGTC
ATGGGTTCGAATCCGGAAACAGCCTCTTTGCATATGCAAGGGTAAGGTTGCGTACAACATCCCTCCCCCATACCTTCGCATAACGAAGAGCCTCTGAACA
ATGGGG
Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
---|---|---|---|---|---|---|---|---|
GLYMA11G08975.1 | Uncharacterized protein | protein coding | CNT0001962 | 450 | 158 | CDS | Trans | |
GLYMA16G23930.2 | Uncharacterized protein | protein coding | CNT0001962 | 453 | 158 | CDS | Trans |